Mylan CEO Heather Bresch On How Mylan Is Different Than Teva

CEO Heather Bresch talked to Scrip about how she will navigate the company through what has become a rough period for the US generic drug market and validation on complex generics and biosimilars.

Mylan NV CEO Heather Bresch had a message for investors at the pharma industry's big J.P. Morgan Healthcare conference in San Francisco that was as much about what Mylan is not as about what it is. What Mylan is not is Teva Pharmaceutical Industries Ltd.

Bresch was as keen as ever to separate Mylan from the competition, not surprising given that Teva is in the...